Dr John Weight Loss Pharmacy - Products
Mounjaro (Tirzepatide)
Send an e-mail enquiry to Dr John Weight Loss Pharmacy
800 USD
First-in-class medication that activates both GIP and GLP-1 recep
Mounjaro® is a once-weekly injectable prescription medication containing tirzepatide, a first-in-class dual GIP and GLP-1 receptor agonist. It is approved for the treatment of type 2 diabetes and is widely recognized for its powerful weight loss effects, even though it is not officially labeled for that purpose. By mimicking two natural hormones—GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)—Mounjaro helps: Improve blood sugar control Reduce appetite and cravings Slow gastric emptying Promote significant and sustained weight loss Mounjaro is available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, and is administered via a simple, prefilled pen once a week. It is typically prescribed as part of a comprehensive treatment plan that includes a healthy diet, exercise, and lifestyle changes. A weight loss–specific version of tirzepatide is marketed under the brand Zepbound.
